Appelhans Dannielle, DIR, reported a transaction classified as grant at HALOZYME THERAPEUTICS, INC. involving 1161.000000 shares for an estimated $0.00. Reported holdings after the transaction were 1161.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
Form 4 relationship flags and nearby filing context
No officer title
Represents restricted stock units granted under the Issuer's director compensation program. Each stock unit represents the right to receive one share of common stock and is scheduled to vest on the
date of the Issuer's 2027 annual meeting of stockholders.
Represents stock options granted under the Issuer's director compensation program. This grant will vest in full on the date of the Issuer's 2027 annual meeting of stockholders.
0 other filings
0 recent txs